Rick Robinson
Pharma in Focus recently interviewed Rick Robinson, Norton Rose Fulbright’s global co-head of life science and healthcare and his Australian colleague and Norton Rose Fulbright partner Richard Fogl.
Richard Fogl
Discussing Australia’s drive for more transparency in the medical systems, both Robinson and Fogl caution within the article that “Australia should not ‘rush’ into a system of greater reporting until the US experience becomes clearer.”
Read the full article, Legal warning on new transparency.
Pharma in Focus is a periodical that covers the pharma sector—both prescription and non-prescription—in Australia and New Zealand.
